miR-4516 is a Novel Prognostic Biomarker and Promotes Tumorigenesis via Targeting PTPN14-Mediated Regulation of the Hippo Pathway in Glioblastoma

Cui, T.; Bell, E. H.; McElroy, J.; Becker, A.; Gulati, P.; Geurts, M.; Mladkova, N.; Gray, A.; Liu, K.; Yang, L.; Liu, Z.; Fleming, J.; Haque, S. J.; Robe, P.; Chakravarti, A.